8-K

                          UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D. C. 20549



                            FORM 8-K

                         CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
                              1934



Date of Report (Date of earliest event reported):  June 27, 2003



                      HEMACARE CORPORATION
     (Exact Name of Registrant as Specified in its Charter)



                           CALIFORNIA
         (State or other jurisdiction of incorporation)



      000-15223                          95-3280412
(Commission File No.)         (IRS Employer Identification No.)



                       21101 Oxnard Street
                    Woodland Hills, CA 91367
      (Address of principal executive offices and Zip Code)



Registrant's telephone number, including area code: (818) 226-1968

                              -1-



ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE

The text of a press release dated June 27, 2003, issued by
HemaCare Corporation ("HemaCare") annoucing the appointment of
Rose Marcario as Chief Financial Officer is attached as
Exhibit 99.1 hereto and is incorporated by reference herein.


ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

(c) Exhibits

Exhibit Number   Description

99.1             Press Release issued by HemaCare, dated
                 June 27, 2003


                           SIGNATURES

Pursuant  to the requirements of the Securities Exchange  Act  of
1934, the registrant has duly caused this report to be signed  on
its behalf by the undersigned hereunto duly authorized.



Date: June 27, 2003           HEMACARE CORPORATION

                             /s/ Judi Irving
                             ----------------------------
                              Judi Irving,
                              Chief Executive Officer




                          EXHIBIT INDEX

Exhibit Number   Description
- --------------   -----------
99.1             Press Release issued by HemaCare, dated June
                 27, 2003


                                 -2-

EX-99

                      LOGO


              N E W S   R E L E A S E


For Immediate Release

Contact:  HemaCare Corporation
	  JoAnn Stover, Director of Investor Relations
          877.310.0717
	  www.hemacare.com



   MARCARIO JOINS HEMACARE AS CHIEF FINANCIAL OFFICER

- -----------------------------------------------------------

     Los Angeles, CA, June 27, 2003 - HemaCare Corporation (OTC
Bulletin Board: HEMA) announced today the appointment of Rose
Marcario as the Company's Chief Financial Officer.
Marcario brings to HemaCare 20 years of achievement in
financial leadership and consultancy roles. Marcario recently
served as the Sr. Vice President & CFO of publicly traded
General Magic, Inc. and Vice President of Global Finance at NYSE
listed International Rectifier Corporation.

     "Rose brings a wealth of knowledge and experience in the
public arena.  In addition to her financial focus, she will play
a key role in working with the management team on the direction,
evaluation and execution of our business plan," stated Judi
Irving, HemaCare's President and Chief Executive Officer.

     Marcario replaces David Fractor as the Company's CFO.
"We thank David for his four years of service at HemaCare,"
stated Irving. "The Company will benefit from the financial
structure he put in place and the relationships he established
with the financial community."


              ABOUT HEMACARE CORPORATION

     Founded in 1978, HemaCare is a national provider of blood
products and services and the only publicly traded company
engaged in the blood services industry in the U.S.  HemaCare
is licensed by the FDA and accredited by the American
Association of Blood Banks.  The Company focuses on providing
cost effective, high quality solutions to the blood-related
needs of U.S. hospitals.

This press release may contain "forward-looking statements"
within the meaning of the term in the Private Securities
Litigation Reform Act of 1995 (Section 27A of the Securities
Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended).  Additional written or
oral forward-looking statements may be made by the Company
from time to time in filings with the Securities
and Exchange Commission or otherwise.  Statements contained
herein that are not historical facts are forward-looking
statements pursuant to the safe harbor provisions referenced
above.  Forward-looking statements are inherently subject to
risks and uncertainties some of which cannot be predicted or
quantified.  Such risks and uncertainties include, without
limitation, the risks and uncertainties set forth from
time to time in reports filed by the Company with the
Securities and Exchange Commission.  Although the Company
believes that the expectations reflected in such forward-
looking statements are reasonable, it can give no assurance
that such expectations will prove to be correct.
Consequently, future events and actual results could differ
materially from those set forth in, or contemplated by,
the forward-looking statements contained herein.  The
Company undertakes no obligation to publicly release any
revision to these forward-looking statements made to
reflect events or circumstances after the date hereof.

                         ###